Fact sheet: Janus Gbl Life Sci

Fund information

Fund name
Janus Global Life Sciences A Acc USD
Fund company manager
Janus Capital Funds
Fund type
SIB
Fund manager
Ethan Lovell
since 12/01/2016
Fund objective
This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

5.42 %

1 Year rank in sector

16/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.9 b

FE Risk score

156

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    77.78%
  • UK
    6.95%
  • France
    4.36%
  • Switzerland
    3.81%
  • Money Market
    2.66%
  • Biotechnology/Medical
    36.17%
  • Pharmaceuticals
    26.41%
  • Health Care
    16.61%
  • Healthcare & Medical Products
    14.17%
  • Hospital
    2.74%
  • US Equities
    77.32%
  • International Equities
    19.57%
  • Cash & Cash Equivalents
    2.66%
  • Convertibles
    0.41%
  • Other International Equities
    0.04%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-2.44 %7.6 %5.42 %21.35 %127.46 %
Sector-3.01 %3.2 %5.23 %23.51 %98 %
Rank within sector18 / 307 / 2916 / 2913 / 265 / 23
Quartile th3 rd1 st3 rd2 nd1 st

Calendar performance

YTD-20172016201520142013
Fund17.49 %-13.79 %5.69 %32.75 %52.45 %
Sector11.87 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector7 / 2919 / 2918 / 2713 / 248 / 23
Quartile th1 st3 rd3 rd3 rd2 nd

Risk statistics

Alpha-0.06
Beta1.04
Sharpe0.29
Volatility16.91
Tracking error5.35
Information ratio0.01
R-Squared0.9

Price movement

52 week high30.35
52 week low23.64
Current bid price0
Current offer price0
Current mid price29.24

Holdings by region

  • 77.78% USA
  • 6.95% UK
  • 4.36% France
  • 3.81% Switzerland
  • 2.66% Money Market
  • 1.58% Japan
  • 1.21% Denmark
  • 0.92% Germany
  • 0.39% Canada
  • 0.31% Hungary

Holdings by sector

  • 36.17% Biotechnology/Medical
  • 26.41% Pharmaceuticals
  • 16.61% Health Care
  • 14.17% Healthcare & Medical Products
  • 2.74% Hospital
  • 2.66% Cash & Cash Equivalents
  • 1.24% Others

Holdings by asset type

  • 77.32% US Equities
  • 19.57% International Equities
  • 2.66% Cash & Cash Equivalents
  • 0.41% Convertibles
  • 0.04% Other International Equities

Individual holdings

  • 3.54% LILLY (ELI) & CO
  • 3% AETNA INC NEW
  • 2.89% CELGENE CORP
  • 2.89% SHIRE PLC
  • 2.88% SANOFI
  • 2.7% ASTRAZENECA PLC
  • 2.6% REGENERON PHARMACEUTICALS INC
  • 2.41% ALLERGAN PLC
  • 2.23% ANTHEM INC
  • 2.14% BOSTON SCIENTIFIC CORP